Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels
Effect of Common Bean Baked Snack (Phaseolus Vulgaris L.) Consumption on Blood Lipid Levels and Hormones Regulating Appetite and Satiety: Randomized Crossover Clinical Trials
1 other identifier
interventional
25
1 country
1
Brief Summary
Introduction: The Mexican population consumes vegetables and snacks with the same frequency. Besides, most of the snacks available on the market contain high fat, sodium and calorie, and low protein levels. Regular consumption of these snacks and low physical activity could promote the development of noncommunicable diseases. Common bean-based snacks are potential healthier alternatives to replace conventional snacks. Hypothesis: The consumption of a common bean baked snack (Phaseolus vulgaris L.) reduces blood lipid levels in overweight people with altered blood lipid levels. Objectives: Evaluate the effect of common bean baked snack consumption on blood lipid levels in overweight people with altered blood lipid levels. Material and Methods: Randomized crossover clinical trial, 28 patients with altered blood lipid levels, 18-40 years old, snack supplementation for four weeks, clinical and laboratory determinations, such as total cholesterol, triglycerides, LDL, HDL, among others.
- Intervention phase: Common bean baked snack intervention.
- Control phase B: No intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started May 2021
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2021
CompletedFirst Submitted
Initial submission to the registry
August 20, 2021
CompletedFirst Posted
Study publicly available on registry
August 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2021
CompletedDecember 10, 2021
December 1, 2021
4 months
August 20, 2021
December 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from baseline in the mean low-density lipoprotein (mg/dL) at 28 days
Baseline and 28 days
Change from baseline in the mean high-density lipoprotein (mg/dL) at 28 days
Baseline and 28 days
Change from baseline in the mean total cholesterol (mg/dL) at 28 days
Baseline and 28 days
Change from baseline in the mean triglycerides (mg/dL) at 28 days
Baseline and 28 days
Study Arms (2)
Snack
EXPERIMENTAL32 g of a common bean baked snack per day for 28 days.
Control
NO INTERVENTIONInterventions
Participants will consume 32 g of a common bean baked snack per day for 28 days during the intervention stage.
Eligibility Criteria
You may qualify if:
- BMI between 25.0 and 29.9 kg/m2,
- Abnormal serum lipid levels:
- Total cholesterol: ≥200 mg/dL,
- Low-density lipoproteins: 100 to 190 mg/dL,
- High-density lipoproteins: \<50 mg/dL in females and \<40 mg/dL in males,
- Triglycerides: 150 to 500 mg/dL.
You may not qualify if:
- Pregnancy or lactation,
- Plans to lose or gain weight in the next three months,
- Modification of diet or physical activity in the last three months,
- Diagnosis of diabetes, cancer, hypertension, heart disease, gastrointestinal disorder, pancreatitis, kidney, liver or thyroid disease,
- Smoking or drug use,
- Sensitivity for bean consumption,
- Pharmacological treatment or consumption of non-prescription drugs, herbal or nutritional supplements known to modify serum lipid levels.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
Guadalajara, Jalisco, 44340, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edgar A. Rivera León, PhD
Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 20, 2021
First Posted
August 31, 2021
Study Start
May 3, 2021
Primary Completion
September 10, 2021
Study Completion
September 10, 2021
Last Updated
December 10, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share
Non-shareable data.